Co-Editor-in-Chief @JCardFail | Chief of the HF Section @DukeHealth | Trialist @DCRInews | Father of 3

Joined June 2009
655 Photos and videos
Robert Mentz, MD retweeted
Jun 10
New issue alert 📘 The June issue of @JCardFail features emerging therapies for acute HF and PH-HFpEF, plus the HFSA Scientific Statement on HFmrEF. 🔗 Read now: onlinejcf.com/current#
6
21
1,860
Robert Mentz, MD retweeted
What's new in heart failure research? Find out in the June edition of JCF, featuring expert perspectives advancing our understanding of heart failure and informing patient care. Read the full issue: onlinejcf.com/current
2
6
9
894
Robert Mentz, MD retweeted
Jun 5
Ejection fraction is useful, but imperfect. #HFmrEF highlights the need to assess myocardial function beyond EF alone. HFSA offers a broader framework: hfsa.org/heart-failure-mildl… @WilcoxHeart @robmentz @dranulala
1
6
13
1,237
Robert Mentz, MD retweeted
Looking forward to tomorrow's Duke's Annual Heart Failure Symposium, but first catch up with friends and colleagues! #heartsuccess #wellness #patientcare
2
21
2,301
Robert Mentz, MD retweeted
Time is running out to submit to JCF’s Focus Issue - Artificial Intelligence and Heart Failure: A Critical Juncture. If your work advances responsible innovation in HF care, now is the time to contribute.⌛ 🗓️ Deadline: June 15th, 2026 bit.ly/4kJl5gf #AIinHealthcare
1
4
13
2,059
Robert Mentz, MD retweeted
In HELIOS-B, vutrisiran slowed renal decline in ATTR-CM: fewer ≥40% eGFR drops vs placebo (12.7% vs 21.2%). Benefits on CV outcomes were consistent across kidney function, even in advanced CKD. Improves not just CV outcomes but has renal benefits🫀🧪 bit.ly/3Q2hhf1
12
19
1,966
Interested in CV clinical trials? Tremendous insights shared by the ANTHEM-HF investigators about RCT complexity after the sponsor terminated the study early @dranulala @DrMarthaGulati @mkonstam @SVRaoMD @DrCaliff_FDA @coconnormd tctmd.com/news/anthem-hfref-…

1
1
16
3,140
Robert Mentz, MD retweeted
Cardiac sarcoidosis: beyond steroids? The REPAIR-CS trial is testing rilonacept (IL-1 blockade) added to standard therapy, with FDG-PET inflammation as the primary endpoint—marking a shift toward targeted, mechanism-based treatment.🫀 🔗 bit.ly/3RijCTs
1
11
21
2,579
Robert Mentz, MD retweeted
Congratulations to the latest DCRI Fellowship Program cohort! Since 1996, the program has provided advanced clinical research training 300 fellows. Learn more: dcri.org/education/fellowshi… #ClinicalResearch #Mentorship
2
11
1,744
Robert Mentz, MD retweeted
May 30
ICYMI 📘 The latest @JCardFail Focus Issue explores inflammatory and infiltrative cardiomyopathies, including myocarditis, amyloidosis, sarcoidosis, AI applications, patient-centered outcomes, and more. Featuring guest editors Drs. Nisha A. Gilotra, Mathew Maurer and Emer Joyce. Plus, a new episode of #HFBeat is coming soon, featuring more insights from this issue. 🔗 Explore the issue: onlinejcf.com/current# @robmentz @dranulala
2
5
668
Robert Mentz, MD retweeted
When should we biopsy for cardiac sarcoidosis? In ILLUMINATE-CS, EMB positivity (~22%) was directionally associated with established predictors (MIDFIN). Novel predictors: septal thickness, FDG-PET burden, BNP). EMBx yield rose stepwise with number of criteria. 🧵
1
6
13
1,531
Robert Mentz, MD retweeted
Thrilled to share that our paper is out in @NEJMEvidence. Using a Weighted Composite Endpoint (WCE), we analyzed AFib trial data and assessed DOAC effects through a patient preference-informed metric. Grateful to all mentors and collaborators! evidence.nejm.org/doi/full/1…
1
4
10
1,368
Robert Mentz, MD retweeted
Now in the @JCardFail, #HFC members @TheHeartBeat3 @JavedButler1 @LindenfeldJoann et al present the design and rationale of the BENEFIT-HF trial evaluating baroreflex activation therapy in symptomatic HFrEF and HFmrEF. sciencedirect.com/science/ar…
7
12
952
Robert Mentz, MD retweeted
The latest State of the Art Review looks at Immune-mediated pericardial & myocardial syndromes as unified spectrum: linking 🧬 susceptibility, 🌍 triggers & systemic inflammation, with integrated diagnostics & expanding therapies (incl. biologics). 🔗 bit.ly/4dEFcZX
1
13
19
1,194
Robert Mentz, MD retweeted
Now in the @JCardFail, #HFC members present a practical Bayesian framework for survival analysis in HF clinical trials. The study highlights how Bayesian methods may improve interpretability and incorporate prior evidence across studies. onlinejcf.com/article/S1071-…
1
7
13
1,846
Robert Mentz, MD retweeted
Acute myocarditis: who is truly at risk? In a real-world cohort, most patients had favorable outcomes (~88% event-free at 10 yrs). But higher risk was linked to age, HF symptoms and LV hypokinesia, highlighting the value of early bedside assessment.🫀📊 bit.ly/4dSSd39
1
7
12
730
Robert Mentz, MD retweeted
And we are exploring this further (simultaneous early initiation of nsMRA plus SGLT2i) vs usual care in acute HF irrespective of EF: stay tuned for CONFIRMATION-HF, we are nearly 40% enrolled globally in this 1,500 patient RCT.
6
15
1,739
Robert Mentz, MD retweeted
Cardiovascular and Renal Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis academic.oup.com/ehjqcco/art… @MushoodCh @FudimMarat @SJGreene_md
2
6
26
4,800
Robert Mentz, MD retweeted
Not too late to register! Key note speaker--> @NMHheartdoc And many guest speakers @RyanTedfordMD @AminYehyaMD Over 30 exhibitors, Hands on Sessions and ... June 6 in Durham medicine.duke.edu/news/calen… @robmentz @Steph_BarnesNP @richa_agarwalMD @manesh_patelMD @DukeHrtFailure

Mark it down ➡️ June 6, 2026 💙 Duke Heart Failure Symposium - The South-East Meeting on ALL around the topic of Heart Function, Implementation and Innovation. World-class faculty and exhibitors are guaranteed! Registration page ⬇️ medicine.duke.edu/education-…
7
17
3,362
Robert Mentz, MD retweeted
From the congress to my clinic - what to take home from #HeartFailure26? Join Brenda Moura and @robmentz, hosted by Felix Lindberg, as they translate the most impactful science from Heart Failure 2026 into practical clinical insights for everyday care. A concise, expert-led discussion connecting emerging evidence with real-world heart failure management. #HeartFailure #Cardiology #ESCTV
1
3
10
1,407